M379A Mutant Tyrosine Phenol‐lyase from Citrobacter freundii Has Altered Conformational Dynamics
Sign Up to like & getrecommendations! Published in 2022 at "Chembiochem"
DOI: 10.1002/cbic.202200028
Abstract: The M379A mutant of Citrobacter freundii tyrosine phenol‐lyase (TPL) has been prepared. M379A TPL is a robust catalyst to prepare a number of tyrosines substituted at the 3‐position with bulky groups that cannot be made… read more here.
Keywords: tyrosine phenol; m379a mutant; m379a tpl; citrobacter freundii ... See more keywords
Coupling heavy metal resistance and oxygen flexibility for bioremoval of copper ions by newly isolated Citrobacter freundii JPG1.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of environmental management"
DOI: 10.1016/j.jenvman.2018.08.042
Abstract: The potential for bioremoval of copper ions was investigated by a novel strain of bacterium Citrobacter freundii JPG1, which was newly isolated from gold mining tailing in China and grew either aerobically or anaerobically. The… read more here.
Keywords: copper; bioremoval copper; freundii jpg1; citrobacter freundii ... See more keywords
Whole genome analysis of multidrug-resistant Citrobacter freundii B9-C2 isolated from preterm neonate's stool in the first week.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of global antimicrobial resistance"
DOI: 10.1016/j.jgar.2020.03.024
Abstract: Abstract Background Resistance to colistin, the last line therapy for infections caused by multidrug-resistant Gram-negative bacteria, represents a major public health threat. Citrobacter freundii B9-C2 which was isolated from the stool of preterm neonate on… read more here.
Keywords: multidrug resistant; freundii isolated; genome; citrobacter freundii ... See more keywords
Whole Genome Sequencing of a Citrobacter freundii Strain Isolated from the Hospital Environment: An Extremely Multiresistant NDM-1 and VIM-48 Coproducing Isolate.
Sign Up to like & getrecommendations! Published in 2021 at "Microbial drug resistance"
DOI: 10.1089/mdr.2020.0417
Abstract: Citrobacter freundii has acquired resistance to several antimicrobial drugs, including last-resort antibiotics affecting, therefore, clinical efficacy and causing high rates of mortality. In this study, we investigate the whole genome sequence of a carbapenem-resistant C.… read more here.
Keywords: strain; citrobacter freundii; resistance; whole genome ... See more keywords
Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying blaKPC-2 Reveals a Heterogenous Population and Reversible Genotype
Sign Up to like & getrecommendations! Published in 2018 at "mSphere"
DOI: 10.1128/msphere.00408-18
Abstract: The development of ceftazidime-avibactam resistance among KPC-producing isolates during treatment with this agent has been reported. Usually isolates that become resistant have a mutated blaKPC gene that confers resistance to ceftazidime-avibactam and susceptibility to meropenem.… read more here.
Keywords: ceftazidime avibactam; avibactam resistance; citrobacter freundii; blakpc ... See more keywords
Biosynthesis of silver nanoparticles from Citrobacter freundii as antibiofilm agents with their cytotoxic effects on human cells.
Sign Up to like & getrecommendations! Published in 2020 at "Current pharmaceutical biotechnology"
DOI: 10.2174/1389201021666201020162158
Abstract: BACKGROUND Nanomaterials have recently been identified for their potential benefits in the areas of medicine and pharmaceuticals. Among these nanomaterials, silver nanoparticles (Ag-NPs) have been widely utilized in the fields of diagnostics, antimicrobials, and catalysis.… read more here.
Keywords: silver nanoparticles; cytotoxic effects; effects human; citrobacter freundii ... See more keywords
Genetic Diversity, Multidrug Resistance, and Virulence of Citrobacter freundii From Diarrheal Patients and Healthy Individuals
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2018.00233
Abstract: Objectives: Citrobacter freundii is a frequent cause of nosocomial infections and a known cause of diarrheal infections, and has increasingly become multidrug resistant (MDR). In this study, we aimed to determine the genetic diversity, the… read more here.
Keywords: healthy individuals; genetic diversity; virulence; resistance ... See more keywords
Biochemical and Molecular Characteristics of a Novel Hyaluronic Acid Lyase from Citrobacter freundii
Sign Up to like & getrecommendations! Published in 2022 at "Foods"
DOI: 10.3390/foods11131989
Abstract: The Gram-negative strain of Citrobacter freundii, YNLX, has the ability to degrade hyaluronic acid. In this study, we expressed a C. freundii hyaluronic acid lyase, from polysaccharide lyase family 8, in Escherichia coli. The purified… read more here.
Keywords: citrobacter freundii; acid lyase; acid; hyaluronic acid ... See more keywords
Designing mRNA- and Peptide-Based Vaccine Construct against Emerging Multidrug-Resistant Citrobacter freundii: A Computational-Based Subtractive Proteomics Approach
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58101356
Abstract: Background and Objectives: Citrobacter freundii (C. freundii) is an emerging and opportunistic Gram-negative bacteria of the human gastrointestinal tract associated with nosocomial and severe respiratory tract infections. It has also been associated with pneumonia, bloodstream,… read more here.
Keywords: computational based; multidrug resistant; citrobacter freundii; vaccine construct ... See more keywords